Süt ve Süt Ürünlerinin Fonksiyonel Özellikleri

Abstract

-

Keywords

• -

SÜT VE SÜT ÜRÜNLERİNİN FONKSİYONEL ÖZELLİKLERİ - FUNCTIONAL PROPERTIES OF MILK AND DAIRY PRODUCTS

Abstract

SÜT VE SÜT ÜRÜNLERİNİN FONKSİYONEL ÖZELLİKLERİ

Fonksiyonel süt ürünleri besleyici etkilerinin yanında sağlık üzerine olumlu etkiler oluşturmayı hedefleyen süt ürünleridir. Tüketiciler tarafından fonksiyonel süt ürünlerine olan ilgi her geçen gün hızla artmaktadır. Sağlığa etkileri açısından fonksiyonel süt ürünlerinin kanser, koroner kalp hastalığı, osteoporoz ve gıda alerjisi olmak üzere birçok rahatsızlık üzerine etkisi bulunmaktadır. Fonksiyonel süt ürünlerinde kazeinfosfopeptit, oligosakkarit, laktik asit bakterileri, konjuge linoleik asit ve diyet lifleri olmak üzere farklı türden bileşenleri kullanılmaktadır. Süt teknolojisine kazandırılacak yeni uygulamalarla fonksiyonel süt ürünlerinin çeşitliliği arttırılacak ve toplum beslenmesine özellikle çocukların gelişimine önemli derecede katma değer sağlayacaktır.

FUNCTIONAL PROPERTIES OF MILK AND DAIRY PRODUCTS

Functional dairy products are to aim at creating a positive impact on the health side effects of nutritious dairy products. The interest in functional dairy products by consumers is daily rapidly increasing. Functional dairy products has effect on many diseases including. cancer, coronary heart disease, osteoporosis and food allergy. Caseinophosphopeptide, oligosaccharide, lactic acid bacteria, conjugated linoleic acid and dietary fiber components are used in different types at functional dairy products. The gains of the new applications to dairy technology will be increased diversity of functional dairy products and will provide significant added value to community’s nutrition especially for children.

Keywords

• Fonksiyonel süt ürünleri, laktik asit bakterileri, konjuge linoleik asit, diyet lifleri

References

1. De Vrese, M. ve Schrezenmeir, J.; Pro and prebiotics, Innov Food Technol, May/ June, 49–55, (2001).
2. Saxelin, M., Grenow, B., Svennson, U., Fonden R., Reneiro, R. ve Mattila-Sandholm, T.; The technology of probiotics , Trends Food Sci Technol, 10, 387–392, (1999).
3. Capela, P., Hay, T.K.C., Shah, N.P.; Effect of cryoprotectants, prebiotics and microencapsulation on survival of probiotic organisms in yoghurt and freze-dried yoghurt . Food Res Int, 39: 203-211, (2006).
4. Sipola, M.; Effects of milk products and milk protein-derived peptides on blood pressure and arterial function in rats, PhD Thesis, Institute of Biomedicine/ Pharmacology, University of Helsinki; electronic PDF version: http://ethesis.helsinki.fi/julkaisut/laa/biola/vk/sipola /, (2002).
5. Seppo, L., Jauhianen, T., Poussa, T. ve Korpela, R.; A fermented milk, high in bioactive peptides, has a blood pressure lowering effect in hypertensive subjects, Am J Clin Nutr, in pres, (2002).
6. Sharma, R., Sanguansri,P., Marsh,R., Sanguanshri,L., Augustin, M.A.; Applications of microencapsulated omega-3 fatty acids in dairy products. The Australian J Dairy Technol. Vol.58.No:2.p.211, (2003).
7. Heasman, M. ve Mellentin, J.; New NuVim prepares to be swallowed up, NNB, 7(8), 29–30, (2002).
8. IARC; Cancer Incidence in Five Continents, Volume VII. France: IARC Scientific Publications, i–xxxiv, 1–1240, (1997).

9. Marcus, P.M. ve Newcomb P.A.; The association of calcium and vitamin D, and colon and rectal cancer in Wisconsin women. Int J Epidemiol, 27, 788–793, (1998).
10. Kampman, E., Slattery, M.L., Caan, B. ve Potter, J.D.; Calcium, vitamin D, sunshine exposure, dairy products and colon cancer risk (United States). Cancer Causes & Control 11, 459– 466, (2000).
11. Bounous, G., Papenburg, R., Kongshavn, P.A, Gold, P. ve Fleiszer, D.; Dietary whey protein inhibits the development of dimethylhydrazine induced malignancy. Clin Invest Med, 11, 213–217, (1988).
12. Papenburg, R., Bounous, G., Fleiszer, D. ve Gold, P.; Dietary milk proteins inhibit the development of dimethylhydrazine-induced malignancy. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 11, 129–136, (1990).
13. Hakkak, R., Korourian, S., Ronis, M.J., Johnston, J. M ve Badger, T.M.; Dietary whey protein protects against azoxymethane-induced colon tumors in male rats. Cancer Epidemiol Biomarkers Prev 10, 555–558, (2001).
14. Banni, S., Day, B.W., Evans, R.W., Corongiu, F.P. ve Lombardi, B..; Detection of conjugated diene isomers of linoleic acid in liver lipids of rats fed a choline-devoid diet indicated that the diet does not cause lipoperoxidation. J Nutr Biochem, 6, 281–289,(1995).
15. Sebedio, J.L., Juaneda, P., Dobson, G., Ramilison, I., Martin, J.D. ve Chardigdy, J.M.; Metabolites of conjugated isomers of linoleic acid (CLA) in the rat. Biochim Biophys Acta, 1345, 5– 10, (1997).
16. Hepner, G., Fried, R., St Jeor, S., Fusetti, L. ve Morin, R.; Hypocholesterolemic effect of yogurt and milk, Am J Clin Nutr ,32, 19–24, (1979).
17. Agerbaek, M., Gerdes, L.U. ve Richelsen, B.; Hypocholesterolaemic effects of a new product in healthy middle-aged men, Eur J Clin Nutr,49, 346– 352, (1995).
18. Sessions, V.A., Lovegrove, J.A., Taylor, G.R.J., Dean, T.S., Williams, C.M., Sanders, A.B., Macdonald, I. ve Salter, A. ; The effects of a new fermented milk product on total plasma cholesterol: LDL cholesterol and apolipoprotein B concentrations in middle aged men and women, Proc Nutr Soc, 56, 120A, (1997).
19. Jackson, K.G., Taylor, G.R.J., Clohessy, A.M. ve Williams, C.M.; The effect of the daily intake of inulin on fasting lipid, insulin and glucose concentrations in middle-aged men and women, BJN ,82, 23–30, (1999).
20. Roberfroid, M.B.; Prebiotics and synbiotics: concepts and nutritional properties, BJN (1998) 80 , S197–S202, (1998).
21. Dawson-Hughes, B., Dallal, G.E., Krall, E.A., Sadowski, L., Sahyoun, N. ve Tannenbaum, S.; A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women, N Engl J Med, 323(13), 878–883,(1990).
22. Dawson-Hughes, B.; Calcium supplementation and bone loss: a review of controlled clinical trials, Am J Clin Nutr, 54(1 Suppl), 274S–280S, (1991).
23. Elders, P.J., Netelenbos, J.C., Lips, P., Van Ginkel F.C., Khoe, E., Leeuwenkamp, O.R., Hackeng, W.H. ve Van Der Stelt, P.F. ; Calcium supplementation reduces vertebral bone loss in perimenopausal women: a controlled trial in 248 women between 46 and 55 years of age, J Clin Endocrinol Metab, 73(3), 533–540,(1991).
24. Kulig, M., Bergmann, R., Klettke, U., Wahn, V., Tacke, U. ve Wahn, U. ; Natural course of sensitization to food and inhalant allergens during the first 6 years of life, J Allergy Clin Immunol, 103(6), 1173–1179,(1999).
25. Loskutova, I.E.; Effectiveness of using Maliutka and Malysh adapted propionic– acidophilus mixtures in the combined treatment of congenital hypotrophy, Vopr-Pitan, May–June, 17– 20;(1985).
26. Trapp, C.L., Chang, C.C., Halpern, G.M., Keen, C.L. ve Gershwin, M.E.; The influence of chronic yoghurt consumption on population of young and elderly adults, Int J Immunother, 9, 53– 64,(1993).
27. Pessi, T., Sütas, Y., Hurme, M. ve Isolauri, E.; Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG, Clin Exp Allergy, 30, 1804–1808,(2000).
28. Pelto, L., Isolauri, E., Lilius, E.M., Nuutila, J. ve Salminen, S. ; Probiotic bacteria down regulate the milk-induced inflammatory response in milkhypersensitive subjects but have an immunostimulatory effect in healthy subjects, Clin Exp Allergy, 28(12), 1474–1479,(1998).
29. Berrocal, R., Chanton, S., Juillerat, M.A., Pavillard, B., Scherz, J.C. ve Jost, R. ; Tryptic phosphopeptides from whole casein: II. Physicochemical properties related to the solubilisation of calcium, J Dy Res, 56, 335– 341,(1989).
30. Sato, R., Shindo, M., Gunshin, H., Noguchi, T. ve Naito, H. ; Characterisation of phosphopeptide derived from bovine β-casein: an inhibitor to intraintestinal precipitation of calcium phosphate, Biochim Biophys Acta, 1077, 413–415,(1991).
31. Gaucheron, F., Le Great, Y., Sinbanhit, S., Guenot, P. ve Brule, G.; Binding of calcium by βcasein in the presence of inorganic phosphate, Sci des Aliments ,15, 481– 489,(1995).
32. Holt, C., Wahlgren, N.M. ve Drakenburg, T. ; Ability of a β-casein phosphopeptide to modulate the precipitation of calcium phosphate by forming amorphous dicalcium phosphate nanoclusters, Biochem J, 314, 1035–1039,(1996).
33. Aoki, T., Nakano, T., Iwashita, T.; Preparation and characterisation of micellar calcium phosphatecasein phosphopeptide complex, J Nutr Sci Vitaminol, 44, 447–456,(1998).
34. Hansen, M., Sandström, B., Jensen, M. ve Sorensen, S.S. ; Casein phosphopeptides improve zinc and calcium absorption from rice-based but not from whole-grain infant cereals, J Ped Gastroent Nutr, 24(1), 56–62,(1997).
35. Roberfroid, M. ve Slavin, J.; Nondigestible oligosaccharides, Crit Rev Food Sci Nutr, 40, 461– 480,(2000).
36. ] Lee, H., Park, Y.,Jung, J. ve Shin, W.;Chitozan oligosaccharides have prebiotic effect on the Bifidobacterium bifidum and Lactobacillus spp., Anaerobe,8:319-324,(2002).
37. Shin, H.S., Lee, H., Pestka, J.J. ve Ustunol, Z.; Growth and viability of commercial Bifidobacterium spp. in milk taining oligosaccharides and inülin. J Food Sci,65(5):884887,(2000).
38. Rivero-Urgell, M. ve Santamaria-Orleans, A.; Oligosaccharides: application in infant food, Early Human Development, 65 (Suppl), S43–52,(2001). [39] Marx, S.P., Winkler,S. ve Hartmeier, W. Metabolization of fructose-oligosaccharides by different bifidobacteria, FEMS Microbiol. Lett, 182:163-169, (2000)
39. Rao, V.A.; The preobiotic properties of oligofructose at low intake levels. Nutr. Res.,21:843-848, (2001).
40. Fitzgerald, R.J.; Potential uses of caseinophosphopeptides, Int Dy J, 8, 451– 457,(1998) [42] Mercenier, A., Pavan, S., Pot, B.; Probiotics as biotherapeutic agents: Present knowledge and future prospects. Curr Pharmaceu Des, 8:99,(2002).
41. Gardiner, G.E., O’Sullivan, E., Kelly, J., Auty, M.A.E., Fitzgerald, G.F., Collins, J.K., Ross, R.P ve Stanton, C. ; Comparitive survival rates of human-derived probiotic Lactobacillus paracasei and L. salivarius strains during heat treatment and spray drying, Appl Envir Microbiol, 66(6), 2605– 2612,(2000).
42. Vinderola, C.G., Prosello, W., Ghiberto, T.D. ve Reinheimer, J.A. ; Viability of probiotic (Bifidobacterium, Lactobacillus acidophilus and Lactobacillus casei) and nonprobiotic microflora in Argentinian Fresco cheese, J Dairy Sci, 83(9), 1905–1911,(2000).
43. Fleichman, W. ve Weigmann, H. ; Die Sauermilcharten’ in Lehrbuch der Milchwirtschaft, 7 Auflage, Berlin, Paul Parey, 369–386,(1932). [46] Kurmann, J., Rasi, J. ve Kroger, M. ; Encyclopedia of Fermented Fresh Milk Products, New York, AVI,(1992).
44. ] Orla-Jensen, S. ve Sadler, W.; Bakteriologische untersuchungen über das isländische Sauermilchpräparat, Zentralblatt f Bakt II Abt, 102, 260, (1940).
45. Larssonn, I. Tätmjölk, tätgräs, surmjölk och skyr, Sthlm Studies Scand Philology, New Series 18, Stockholm, Almqvist and Wicksell (incl. English summary),(1988).
46. Burke, A. Practical Manufacture of Cultured Milks and Kindred Products, Milwaukee, Olsen Publishing Co, (1938).
47. Gnadig, S; Konjugierte Linolsäureisomere in Lebensmittlen, humanem Fettgewebe und humanem Blutplasma, Diplomarbeit, Fachbereich Chemie, Inst. für Biochemie und Lebensmittelchemie, Abt. Lebensmittelchemie, Universität Hamburg, Hamburg, (1996).
48. Smedman, A., Vessby, B.; Conjugated linoleic acid supplementation in humans metabolic effects. Lipids; 36: 773-81,(2001).
49. Shantha, N.C., Ram, L.N., O’Leary, J., Hicks, C.L. ve Decker, E.A. ; Conjugated linoleic acid concentrations in dairy products as affected by processing and storage, J Food Res, 60, 695– 720,(1995).
50. Kamphuis, M.M., Lejeune, M.P., Saris, W.H., Westerterp- Plantenga, M.S.; The effect of conjugated linoleic acid supplementation after weight loss on body weight regain, body composition, and resting metabolic rate in overweight subjects. Int J Obes Relat Metab Disord; 27: 840-7,(2003).
51. Sugano, M., Tsujita, A., Yamasaki, M., Noguchi, M., Yamada, K.; Conjugated linoleic acid modulates tissue levels of chemical mediators and immunoglobulins in rats. Lipids; 33: 521-7,(1998).
52. Cesano, A., Visonneau, S., Scimeca, J.A., Kritchevsky, D., Santoli, D.; Opposite effects of linoleic acid and conjugated linoleic acid on human prostatic cancer in SCID mice. Anticancer Res; 18: 1429-34,(1998).
53. Blankson, H., Stakkestad, J.A., Fagertun, H., Thom, E., Wadstein, J., Gudmundsen, O. ;Conjugated linoleic acid reduces body fat mass in overweight and obese humans. J Nutr; 130: 29438,(2000).
54. Young, C.K. ve Nelson, F.E.; Survival of Lactobacillus acidophilus in sweet acidophilus milk during refrigerated storage, J Food Protec, 41(4), 248–250,(1978).
55. Gordon, D.T.; Defining dietary fiber. Cereal Foods World. 44(5): 336,(1999).
56. Dreher, M. ; What is dietary fiber?. Handbook of diertary fiber. Chapter 1,(2002).
57. Ramirez-Santiago, C., Ramos-Solis, L., Lobato-Calleros, C., Peña-Valdivia, C., VernonCarter, E.J., Alvarez-Ramirez, J. ; Enrichment of stirred yogurt with soluble dietary fiber from Pachyrhizus erosus L. Urban: Effect on syneresis, microstructure and rheological properties. J Food Eng, 101(3): 229-235,(2010).
58. Hashim, I.B., Khalil, A.H., Afifi, H.S. ; Quality characteristics and consumer acceptance of yogurt fortified with date fiber. J Dairy Sci. 92(11): 5403-5407,(2009).
59. Soukoulis, C., Lebesi, D., Tzia, C. ; Enrichment of ice cream with dietary fibre: Effects on rheological properties, ice crystallisation and glass transition phenomena, Laboratory of Food Science and Technology, School of Chemical Engineering, National Technical University of Athens, 5 Iroon Polytechniou str., Polytechnioupoli Zografou, 15780 Athens, Greece. Food Chem, 115(2): 665-671;(2008)
60. Sendra, E, Fayos P, Lario,Y,Fernandez-Lopez, J., Perez-Alvarez J.A.; Incorporation of citrus fibers in fermented milk containing probiotic bacteria. Food Microbiol , 25(1):13-21, (2008).